| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.05 |